Opening Medicare to Americans aged 50 to 64 would lower health care premiums for the group, but also drive up costs for younger people who buy health insurance on exchanges created under the federal Affordable Care Act, according ...
Nov 18, 2019
0
2
(HealthDay)—Falls by older Americans have devastating medical and economic consequences, reaching $50 billion a year, a new study finds.
Mar 7, 2018
2
27
A new study from the Harvey L. Neiman Health Policy Institute found that only 1.8% of eligible Americans with commercial insurance received lung cancer screening. Rates were higher but still extremely low for Original Medicare ...
Mar 29, 2023
0
20
Contrary to popular practice, a measure of the heart's pumping function known as "left ventricular ejection fraction" is not associated with the long-term outcomes of hospitalized heart failure patients, a UCLA-led study ...
Nov 12, 2017
0
2
For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents ...
May 15, 2023
0
18
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...
Oct 9, 2017
0
29
Most Americans have never heard of it, but according to new federal data, sepsis is the most expensive cause of hospitalization in the US.
Jul 1, 2015
1
46
Black Medicare patients have lower odds of receiving a surgical consultation after being admitted from the emergency department with an emergency general surgery condition versus similar White Medicare patients, according ...
Oct 18, 2022
0
2
A Medicare system that is meant to assess and incentivize healthcare quality with pay adjustments may not be working as intended, according to a study from researchers at Weill Cornell Medicine.
Dec 6, 2022
0
20
Biologics used to treat patients can be incredibly expensive, so there was significant hope that biosimilar drugs—which are highly similar to an existing biologic drug on the market—could serve as a less-costly substitute. ...
Nov 4, 2019
0
7
